Effect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitus
Yin RV, Phung OJ
Published in Nutrition Journal
Methodology
Systematic review and meta-analysis of randomized controlled trials of chromium supplementation on HbA1c and fasting plasma glucose in type 2 diabetes.
Key Findings
Chromium supplementation produced small reductions in HbA1c and fasting plasma glucose versus placebo, with substantial heterogeneity between trials.
Conclusions
Chromium may modestly improve glycemic markers in diabetes, but evidence quality limits clinical recommendations.
Limitations
Heterogeneous chromium forms and doses, small trials, variable baseline glycemic control and chromium status.
Supplements Studied
Chromium supplementation produced small reductions in HbA1c and fasting plasma glucose versus placebo.
Outcomes Measured
Chromium produced small reductions in fasting plasma glucose.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.